# Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)

> **NCT01395862** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1001 (actual)

## Conditions studied

- Respiratory Disorders

## Interventions

- **DRUG:** Salmeterol and Fluticasone

## Key facts

- **NCT ID:** NCT01395862
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 1001 (ACTUAL)
- **Last updated:** 2013-08-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01395862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01395862, "Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01395862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*